Answers are grounded in this paper and cite their sources.
Objective Neurosarcoidosis affects 5%-10% of patients with sarcoidosis. CD4+/CD8+ ratio in bronchoalveolar lavage is included in diagnostic routine for pulmonary sarcoidosis. Previously, it has been suggested that a cerebrospinal fluid CD4+/CD8+ ratio ≥5 can be an aid in diagnosing neurosarcoidosis. Materials and Methods This study included 66 cases where neurosarcoidosis was a differential diagnosis and hence subjected to the analysis of CSF CD4+/CD8+ ratio by flow cytometry. Results Eleven cases of neurosarcoidosis, had a significantly higher median CSF CD4+/CD8+ ratio than the other group, P = .024. The median CSF CD4+/CD8+ ratio was 4.2, hence not reaching the suggested level of ≥5 for diagnosing neurosarcoidosis. When combined, the elevated CSF CD4+/CD8+ ratio ≥5 and an elevated CSF lymphocyte count (>3 lymphocytes/uL) gave a positive predictive value of 57% and a high negative predictive value of 88%, with a specificity of 95% for neurosarcoidosis. Conclusion The study confirms that increased CSF CD4+/CD8+ ratio is associated with neurosarcoidosis but cannot alone distinguish the conditions from other neurological diagnoses. However, a ratio below <5 combined with an absence of pleocytosis in CSF yields a negative predictive value (NPV) of 88% suggesting a role for the analysis in differential diagnosing neuroinflammatory conditions.
No takes yet. Share an insight, caveat, or question.
Nordström et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: